Simplify Logo

Full-Time

Associate Director

Clinical Data Science

Posted on 3/25/2024

Revolution Medicines

Revolution Medicines

201-500 employees

Specializes in precision oncology therapies

Hardware
Biotechnology
Healthcare

Senior

San Carlos, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Science
Management
Requirements
  • MS, BS/BA with 12+ years of related experience or other suitable qualification
  • Direct experience of designing and running early-stage clinical trials
  • Knowledge of databases, standards, medical terminology, medical coding dictionaries, quality control processes, and auditing procedures
  • Good working knowledge of ICH, FDA, and GCP regulations and guidelines
  • Demonstrable record of strong leadership and teamwork
  • Industry experience
Responsibilities
  • Plans, coordinates, and manages CDM tasks for clinical studies
  • Participate and review CRO proposals
  • Acts as primary liaison with CROs, third party data vendors, EDC vendors
  • Reviews clinical protocols and cross functional plans
  • Oversees and participates in all aspects of EDC database development, testing, maintenance, and lock/unlock
  • Ensures Data Management Plans are followed through the course of the studies
  • Sets and manages Data Management project timelines
  • Provides comprehensive status updates to project team members
  • Address data issues identified by cross-functional team members
  • Assist in defining and creating data listings, summary table validation, data specifications and process data transfers in preparation for statistical review and data management audit
  • Implements data standardization and maintains data model across projects
  • Direct management and mentoring responsibilities for internal data management team members
  • Lead department initiatives e.g., development of SOPs
  • Other duties as assigned

### Welcome to Revolution Medicines, crafting the future of oncology with precision. Our focus is on advancing RAS(ON) inhibitors and RAS Companion inhibitors, marked by the remarkable journey of our lead product, RMC-4630, through its clinical phases. Supported by a team of passionate oncology experts, we are steadfast in our mission to develop treatments that precisely target oncogenic mutations, promising a brighter, healthier tomorrow for patients everywhere. ###

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

46%

2 year growth

111%
INACTIVE